PRINCETON, N.J.--(BUSINESS WIRE)--PharmaNet Development Group, Inc. (NASDAQ: PDGI) (the “Company”), a leading provider of global drug development services, previously disclosed that, effective January 1, 2007, it would begin to report the financial results for PharmaNet Specialized Pharmaceutical Services, Inc. (SPS) in the late stage segment. Prior to 2007, the financial results for SPS were reported in the early stage segment.
